Investigation of solid phase composition on tablet surfaces by grazing incidence X-ray diffraction

Pharmaceutical Research

Volumn 29, Issue 1, 2012, Pages 134-144

  Koradia, Vishal ^a,e   Tenho, Mikko ^b   Lopez De Diego, Heidi ^c   Ringkjøbing Elema, Michiel ^c   Møller Sonnergaard, Jørn ^a   Salonen, Jarno ^b   Lehto, Vesa Pekka ^b,d   Rantanen, Jukka ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF TURKU   (Finland)

^c H LUNDBECK A S   (Denmark)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

^e NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Amorphous; Compaction; Dehydration; Grazing incidence diffraction; Phase transformation

Indexed keywords

AMLODIPINE BESYLATE; NITROFURANTOIN; THEOPHYLLINE; AMLODIPINE;

ACCURACY; ARTICLE; CHEMICAL COMPOSITION; CONTACT ANGLE; CONTROLLED STUDY; CRYSTALLIZATION; DRUG DELIVERY SYSTEM; DRUG STABILITY; GRAZING INCIDENCE X RAY DIFFRACTION; HYDRATION; PARTICLE SIZE; PHASE TRANSITION; PREDICTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SOLID STATE; SURFACE PROPERTY; TABLET COMPRESSION; TABLET FORMULATION; TABLET SURFACE; X RAY DIFFRACTION; CHEMISTRY; COMPRESSIVE STRENGTH; METHODOLOGY; PRESSURE; TABLET;

AMLODIPINE; COMPRESSIVE STRENGTH; CRYSTALLIZATION; NITROFURANTOIN; PRESSURE; SURFACE PROPERTIES; TABLETS; THEOPHYLLINE; X-RAY DIFFRACTION;

EID: 84860563742     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-011-0520-8     Document Type: Article

References (45)

1. Alderborn G, Nyström C. Pharmaceutical powder compaction technology. New York: Marcel Dekker, Inc.; 1995.
2. Hilfiker R, Blatter F, von Raumer M. Relevance of solid-state properties for pharmaceutical products. In: Hilfiker R, editor. Polymorphism: in the pharmaceutical industry. Weinheim: WILLEY-VCH Verlag GmbH & Co.; 2006. p. 1-20.
3. Joiris E, Martino PD, Berneron C, Guyot-Hermann A-M, Guyot J-C. Compression behavior of orthorhombic paracetamol. Pharm Res. 1998;15:1122-30. (Pubitemid 28356933)
4. Sun CQ, Grant DJW. Influence of crystal structure on the tableting properties of sulfamerazine polymorphs. Pharm Res. 2001;18:274-80. (Pubitemid 32595813)
5. Feng YS, Grant DJW, Sun CC. Influence of crystal structure on the tableting properties of n-alkyl 4-hydroxybenzoate esters (Parabens). J Pharm Sci. 2007;96:3324-33.
6. Otsuka M, Nakanishi M, Matsuda Y. Effects of crystalline form on the tableting compression mechanism of phenobarbital polymorphs. Drug Dev Ind Pharm. 1999;25:205-15. (Pubitemid 29072782)
7. Jaffe J, Foss NE. Compression of crystalline substances. J Am Pharm Assoc. 1959;48:26-9.
8. Sun C, Grant D. Improved tableting properties of p-hydroxybenzoic acid by water of crystallization: a molecular insight. Pharm Res. 2004;21:382-6. (Pubitemid 38221986)
9. Bernstein J. Molecular crystals: pinching polymorphs. Nat Mater. 2005;4:427-8.
10. Hüttenrauch R, Fricke S, Zielke P. Mechanical activation of pharmaceutical systems. Pharm Res. 1985:302-306. (Pubitemid 16193203)
11. Brittain HG. Effects of mechanical processing on phase composition. J Pharm Sci. 2002;91:1573-80. (Pubitemid 34680220)
12. Chan HK, Doelker E. Polymorphic transformation of some drugs under compression. Drug Dev Ind Pharm. 1985;11:315-32. (Pubitemid 15067831)
13. Kala H, Haack U, Wenzel U, Zessin G, Pollandt P. Crystallographic behavior of carbamazepine under compression. Pharmazie. 1987;42:524-7.
14. Kala H, Traue J, Haack U, Moldenhauer H, Kedvessy G, Selmeczi B. Time-dependence of polymorphic changes of sulfanilamide during tablet compression. Pharmazie. 1982;37:674-5.
15. Ibrahim HG, Pisano F, Bruno A. Polymorphism of phenylbutazone: properties and compressional behavior of crystals. J Pharm Sci. 1977;66:669-73. (Pubitemid 8091925)
16. Ghan GA, Lalla JK. Effect of compressional forces on piroxicam polymorphs. J Pharm Pharmacol. 1992;44:678-81.
17. Kala H, Moldenhauer H, Giese R, Kedvessy G, Selmeczi B, Pintye-Hodi K. Polymorphism of sulfathiazole and its crystallographic behavior under compression pressure. Pharmazie. 1981;36:833-8. (Pubitemid 12126554)
18. Boldyreva E. High-pressure polymorphs of molecular solids: when are they formed, and when are they not? some examples of the role of kinetic control. Cryst Growth Des. 2007;7:1662-8.
19. Wildfong PL, Morris KR, Anderson CA, Short SM. Demonstration of a shear-based solid-state phase transformation in a small molecular organic system: chlorpropamide. J Pharm Sci. 2007;96:1100-13. (Pubitemid 46797480)
20. Okumura T, Ishida M, Takayama K, Otsuka M. Polymorphic transformation of indomethacin under high pressures. J Pharm Sci. 2006;95:689-700.
21. Otsuka M, Matsumoto T, Kaneniwa N. Effects of the mechanical energy of multi-tableting compression on the polymorphic transformations of chlorpropamide. J Pharm Pharmacol. 1989;41:665-9. (Pubitemid 20022467)
22. Koivisto M, Heinanen P, Tanninen VP, Lehto VP. Depth profiling of compression-induced disorders and polymorphic transition on tablet surfaces with grazing incidence X-ray diffraction. Pharm Res. 2006;23:813-20.
23. Chawla G, Bansal AK. Effect of processing on celecoxib and its solvates. Pharm Dev Technol. 2004;9:419-33. (Pubitemid 39525265)
24. Lefebvre C, Guyot-Hermann AM, Draguet-Brughmans M, Bouche R, Guyot JC. Polymorphic transitions of carbamazepine during grinding and compression. Drug Dev Ind Pharm. 1986;12:1913-27. (Pubitemid 17178854)
25. Wikström H, Marsac PJ, Taylor LS. In-line monitoring of hydrate formation during wet granulation using Raman spectroscopy. J Pharm Sci. 2005;94:209-19. (Pubitemid 40116384)
26. Romer M, Heinamaki J, Miroshnyk I, Sandler N, Rantanen J, Yliruusi J. Phase transformations of erythromycin A dihydrate during pelletisation and drying. Eur J Pharm Biopharm. 2007;67:246-52. (Pubitemid 46991315)
27. Otsuka M, Kanbniwa N, Otsuka K, Kawakami K, Umezawa O. Effect of tableting pressure and geometrical factor of tablet on dehydration kinetics of theophyline monohydrate tablets. Drug Dev Ind Pharm. 1993;19:541-57. (Pubitemid 23063386)
28. Suihko E, Lehto V-P, Ketolainen J, Laine E, Paronen P. Dynamic solid-state and tableting properties of four theophylline forms. Int J Pharm. 2001;217:225-36. (Pubitemid 32268648)
29. Ketolainen J, Poso A, Viitasaari V, Gynther J, Pirttimäki J, Laine E, et al. Changes in solid-state structure of cyclophosphamide monohydrate induced by mechanical treatment and storage. Pharm Res. 1995;12:299-304.
30. Brussel BAV, Hosson JTMD. Glancing angle x-ray diffraction: a different approach. Appl Phys Lett. 1994;64:1585-7.
31. Debnath S, Predecki P, Suryanarayanan R. Use of glancing angle X-ray powder diffractometry to depth-profile phase transformations during dissolution of indomethacin and theophylline tablets. Pharm Res. 2004;21:149-59. (Pubitemid 38122304)
32. Liu J, Saw RE, Kiang YH. Calculation of effective penetration depth in X-ray diffraction for pharmaceutical solids. J Pharm Sci. 2010;99:3807-14.
33. Pienaar EW, Caira MR, Lötter AP. Polymorphs of nitrofurantoin. 2. preparation and X-Ray crystal-structures of two anhydrous forms of nitrofurantoin. J Crystallogr Spectrosc Res. 1993;23:785-90.
34. Koradia V, de Diego HL, Frydenvang K, Ringkjøbing-Elema M, Müllertz A, Bond AD, et al. Solid forms of amlodipine besylate: physico-chemical, structural and thermodynamic characterization. Cryst Growth Des. 2010;10:5279-90.
35. Parratt LG. Surface studies of solids by total reflection of X-rays. Phys Rev. 1954;95:359-69.
36. Cullity BD. Elements of x-ray diffraction. Reading: Addison- Wesley; 1978.
37. Roisnel T, Rodriguez-Carvajal J. WinPLOTR: a windows tool for powder diffraction pattern analysis. Materials Science Forum, Proceedings of the Seventh European Powder Diffraction Conference (EPDIC 7). 378-3:118-123 (2000).
38. Caira MR, Pienaar EW, Lötter AP. Polymorphism and pseudopolymorphism of the antibacterial nitrofurantoin. Mol Cryst Liq Cryst. 1996;279:241-64. (Pubitemid 126577678)
39. Koradia V, de Diego HL, Elema MR, Rantanen J. Integrated approach to study the dehydration kinetics of nitrofurantoin monohydrate. J Pharm Sci. 2010;99:3966-76.
40. Phadnis NV, Suryanarayanan R. Polymorphism in anhydrous theophylline - implications on the dissolution rate of theophylline tablets. J Pharm Sci. 1997;86:1256-63. (Pubitemid 27486097)
41. Debnath S, Suryanarayanan R. Influence of processing-induced phase transformations on the dissolution of theophylline tablets. AAPS PharmSciTech. 2004;5:E8.
42. Busignies V, Leclerc B, Porion P, Evesque P, Couarraze G, Tchoreloff P. Quantitative measurements of localized density variations in cylindrical tablets using X-ray microtomography. Eur J Pharm Biopharm. 2006;64:38-50. (Pubitemid 44150597)
43. Eiliazadeh B, Briscoe BJ, Sheng Y, Pitt K. Investigating density distributions for tablets of different geometry during the compaction of pharmaceuticals. Part Sci Technol. 2003;21:303-16. (Pubitemid 37413342)
44. Hüttenrauch R, Fricke S. Mechano-chemical decomposition of drugs through galenic processes. Int J Pharm. 1979;3:289-90. (Pubitemid 9242002)
45. Karjalainen M, Airaksinen S, Rantanen J, Aaltonen J, Yliruusi J. Characterization of polymorphic solid-state changes using variable temperature X-ray powder diffraction. J Pharm Biomed Anal. 2005;39:27-32. (Pubitemid 41112115)